43
Growth Score in past quarter
pts
Heat Score 43 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3920668
Pairnomix empowers physicians and patients who want to know more about rare genetic mutations and drugs that could be prescribed today.
About the Company
Pairnomix launched in January of 2016 to empower physicians and patients who want to know more about rare genetic mutations and new uses for drugs that could be prescribed to help the patient today. As a personalized genetic research company, the Pairnomix process involves creating a model of a patient’s genetic mutation, learning about the
functional consequences of that mutation, and testing approved drugs against the model to discover new treatment options. Findings are delivered in customized reports to the patient’s physician so together patient and physician can make better-informed healthcare decisions. Additionally, we use the learnings to support rare disease drug discovery and development efforts.